FDA requests removal of Opana ER for risks related to abuse

by Karl Voigt Patients who are taking the pain medication Opana are now facing its manufacturer’s withdrawal of the medication from the market. Earler this year, the US Food and Drug Administration (FDA) concluded that Opana ER “exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to ...Read the full article